---
document_datetime: 2025-01-20 09:58:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ocaliva-epar-all-authorised-presentations_en.pdf
document_name: ocaliva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9158254
conversion_datetime: 2025-12-19 13:22:16.053638
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/16/1139/001 | OCALIVA           | 5 mg       | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 30 tablets  |
| EU/1/16/1139/002 | OCALIVA           | 10 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 30 tablets  |
| EU/1/16/1139/003 | OCALIVA           | 5 mg       | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 100 tablets |
| EU/1/16/1139/004 | OCALIVA           | 10 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE)         | 100 tablets |

<!-- image -->